- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02865941
Target Fortification of Breast Milk: How Often Breast Milk Needs to be Measured? (TFO2)
Target Fortification of Breast Milk: The Effect of Different Schedules for Milk Analysis on the Growth and Development of Preterm Infants.
It has been observed that target fortification on different schedules leads to meal to meal variation. It changes the ratio of protein to energy and the percentage of carbohydrate to non-protein energy which may, affect growth. In the past, the investigators have analyzed the outcomes of breast milk composition when target fortification is done with different analysis schedules. The investigators were able to measure the macronutrient intake for different milk analysis schedules via a theoretical model and show that the more frequent schedules reduce the variation of fortified-breast milk, whereas a reduced schedule leads to a high variation of macronutrients. It was observed that, in all the breast milk samples measured twice per week, infants achieved on average the recommended macronutrients in line with current recommendations. Nonetheless, the model only looks at the macronutrient intake and does not investigates the relationship between macronutrient variation and its effect on growth.
The aim of the current study is to compare a frequent schedule of measurement of macronutrient analysis with a reduced schedule of measurement and to study its affect on growth, protein accretion and metabolic parameter.
Studieoversigt
Status
Betingelser
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Ontario
-
Hamilton, Ontario, Canada, L8S 4K1
- Faculty of Health Science, McMaster Children's Hospital
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Gestational age < 30 weeks (maternal dates or early fetal ultrasound);
- Tolerating an enteral intake of ≥100 mL/kg/d for ≥ 24h;
- Subject is anticipated to receive the intervention for ≥ 3 consecutive weeks after full enteral feeding (≥150 mL/kg/d) has been achieved;
- Written informed consent has been obtained from the infant's legal representative.
- Multiple births: Each infant will be included in the study if he/she meets the study criteria, and siblings will be individually randomized to one or other of the treatment arms.
- Discussion with Most Responsible Physician (MRP) and the staff in order to discuss any potential transfer during the next 7 days.
Exclusion Criteria:
- Gastrointestinal malformation, major congenital anomalies and chromosomal abnormalities;
- Babies with enterostoma or short gut syndrome;
- Infants fed more than 25% of mean caloric intake for a consecutive week with formula milk;
- Fluid restriction <140 mL/kg/d for ≥ 3 consecutive days;
- Sepsis - all infants with gram-negative sepsis will be removed from the study;
- Necrotizing enterocolitis, defined by feeding intolerance associated with positive x-ray findings (pneumatosis intestinalis - Bell Stage 2; air in the biliary tract or free air in the peritoneum - Bell Stage 3);
- Renal disease, defined by symptoms (oliguria, anuria, proteinuria, hematuria) associated with an increased blood urea nitrogen >10 mmol/L and creatinine of 130mmol/L
- Participation in another clinical trial that may provide an alternative nutritional intervention, which might affect the outcomes of this study. outcomes of this study;
- Probability of transfer to another neonatal intensive care unit or level II nursery outside the McMaster Children's Hospital, as discussed with the most responsible physician (MRP)
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: 5 milk analysis
|
Modular product supplementation is based on most recent breast analysis done for the participant.
Modular product supplementation is based on most recent breast analysis done for the participant.
Modular product supplementation is based on most recent breast analysis done for the participant.
|
|
Eksperimentel: 1 milk analysis
|
Modular product supplementation is based on most recent breast analysis done for the participant.
Modular product supplementation is based on most recent breast analysis done for the participant.
Modular product supplementation is based on most recent breast analysis done for the participant.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Growth during first three weeks of intervention
Tidsramme: first three weeks during intervention before 36 weeks of gestation
|
first three weeks during intervention before 36 weeks of gestation
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Daily Nutrient intake (kcal, lactose, protein, fat) measured with conventional milk analysis
Tidsramme: from inclusion at postmenstrual age <30 weeks until 36 weeks of gestation
|
from inclusion at postmenstrual age <30 weeks until 36 weeks of gestation
|
|
|
Weight Gain
Tidsramme: from inclusion at postmenstrual age <30 weeks until 36 weeks of gestation or discharge
|
from inclusion at postmenstrual age <30 weeks until 36 weeks of gestation or discharge
|
|
|
Oxidative stress by 8-Oxo-2'-deoxyguanosine metabolites in urine
Tidsramme: from inclusion at postmenstrual age <30 weeks until discharge
|
Measured by mass spectroscopy
|
from inclusion at postmenstrual age <30 weeks until discharge
|
|
Protein synthesis analyzed by nitrogen excretion in urine [µmol/mL]
Tidsramme: first three weeks during intervention before 36 weeks of gestation
|
first three weeks during intervention before 36 weeks of gestation
|
|
|
Feeding intolerance questionaire
Tidsramme: from inclusion at postmenstrual age <30 weeks until discharge
|
volume of gastric residuals, color of gastric residuals, vomiting, abdominal girth, abdominal distention
|
from inclusion at postmenstrual age <30 weeks until discharge
|
|
Fat mass [g]
Tidsramme: from inclusion at postmenstrual age <30 weeks until discharge
|
Measured with bioelectrical impedance analysis
|
from inclusion at postmenstrual age <30 weeks until discharge
|
|
Lean mass [g]
Tidsramme: from inclusion at postmenstrual age <30 weeks until discharge
|
Measured with bioelectrical impedance analysis
|
from inclusion at postmenstrual age <30 weeks until discharge
|
|
Head circumference [cm]
Tidsramme: from inclusion at postmenstrual age <30 weeks until discharge
|
Measured by tape
|
from inclusion at postmenstrual age <30 weeks until discharge
|
|
Body length [cm]
Tidsramme: from inclusion at postmenstrual age <30 weeks until discharge
|
Measured by length board
|
from inclusion at postmenstrual age <30 weeks until discharge
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Christoph Fusch, MD, PhD, McMaster Children's Hospital
Publikationer og nyttige links
Generelle publikationer
- Fusch G, Rochow N, Choi A, Fusch S, Poeschl S, Ubah AO, Lee SY, Raja P, Fusch C. Rapid measurement of macronutrients in breast milk: How reliable are infrared milk analyzers? Clin Nutr. 2015 Jun;34(3):465-76. doi: 10.1016/j.clnu.2014.05.005. Epub 2014 May 17.
- Rochow N, Fusch G, Choi A, Chessell L, Elliott L, McDonald K, Kuiper E, Purcha M, Turner S, Chan E, Xia MY, Fusch C. Target fortification of breast milk with fat, protein, and carbohydrates for preterm infants. J Pediatr. 2013 Oct;163(4):1001-7. doi: 10.1016/j.jpeds.2013.04.052. Epub 2013 Jun 12.
- Choi A, Fusch G, Rochow N, Sheikh N, Fusch C. Establishment of micromethods for macronutrient contents analysis in breast milk. Matern Child Nutr. 2015 Oct;11(4):761-72. doi: 10.1111/mcn.12053. Epub 2013 Jun 18.
- Fusch G, Choi A, Rochow N, Fusch C. Quantification of lactose content in human and cow's milk using UPLC-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Dec 1;879(31):3759-62. doi: 10.1016/j.jchromb.2011.09.053. Epub 2011 Oct 6.
- Fusch G, Mitra S, Rochow N, Fusch C. Target fortification of breast milk: levels of fat, protein or lactose are not related. Acta Paediatr. 2015 Jan;104(1):38-42. doi: 10.1111/apa.12804. Epub 2014 Oct 2.
- Rochow N, Landau-Crangle E, Fusch C. Challenges in breast milk fortification for preterm infants. Curr Opin Clin Nutr Metab Care. 2015 May;18(3):276-84. doi: 10.1097/MCO.0000000000000167.
- Rochow N, Fusch G, Zapanta B, Ali A, Barui S, Fusch C. Target fortification of breast milk: how often should milk analysis be done? Nutrients. 2015 Apr 1;7(4):2297-310. doi: 10.3390/nu7042297.
- Fusch G, Kwan C, Huang RC, Rochow N, Fusch C. Need of quality control programme when using near-infrared human milk analyzers. Acta Paediatr. 2016 Mar;105(3):324-5. doi: 10.1111/apa.13305. Epub 2016 Jan 19. No abstract available.
- Choi A, Fusch G, Rochow N, Fusch C. Target Fortification of Breast Milk: Predicting the Final Osmolality of the Feeds. PLoS One. 2016 Feb 10;11(2):e0148941. doi: 10.1371/journal.pone.0148941. eCollection 2016.
- Kotrri G, Fusch G, Kwan C, Choi D, Choi A, Al Kafi N, Rochow N, Fusch C. Validation of Correction Algorithms for Near-IR Analysis of Human Milk in an Independent Sample Set-Effect of Pasteurization. Nutrients. 2016 Feb 26;8(3):119. doi: 10.3390/nu8030119.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2016TFO2
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Postnatal vækstforstyrrelse
-
Perelel Inc.University of GeorgiaRekruttering
-
Dhulikhel HospitalRekrutteringPostnatal plejeNepal
-
Duke UniversityAktiv, ikke rekrutterende
-
Eunice Kennedy Shriver National Institute of Child...AfsluttetPostnatal vækst
-
Selcuk UniversityTilmelding efter invitationAmning | Postnatal plejeKalkun
-
Kathrin HILLMANNJohnson & Johnson GmbHAfsluttet
-
JhpiegoBill and Melinda Gates Foundation; Addis Continental Institute of Public...Afsluttet
-
Centre Hospitalier Régional Metz-ThionvilleRekruttering
-
Centre Hospitalier Universitaire de la GuadeloupeInstitut National de la Santé Et de la Recherche Médicale, FranceRekrutteringPrænatal eksponering | Postnatal eksponeringGuadeloupe
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaIkke rekrutterer endnuPludselig uventet postnatal kollaps -opsupcItalien